Study on the Chemical Constituents and anti-HBV Activity of Hypericum japonica

被引:1
作者
Chen, Gao-yun [1 ]
Liu, Min [1 ]
Yu, Meng-bin [1 ]
Zheng, Chao [2 ]
Wei, Si-chen [3 ]
机构
[1] Inst Chem Def, Beijing, Peoples R China
[2] Shantou Univ, Dept Biol, Shantou, Peoples R China
[3] Beijing Univ Chem Technonl, Fac Sci, Beijing, Peoples R China
来源
2016 3RD INTERNATIONAL CONFERENCE ON CHEMICAL AND BIOLOGICAL SCIENCES | 2016年 / 60卷
关键词
HEPATITIS-B-VIRUS; INFECTION; ADEFOVIR;
D O I
10.1051/matecconf/20166003002
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The most common cause of chronic viral hepatitis worldwide is from the Hepatitis B virus (HBV). Screening the safe and effective anti-HBV compounds in traditional Chinese medicine provides a large opportunity for the development of anti-HBV drugs. We found the ethanol extract of H. japonica had the besr inhibitory effects on HBeAg secretion from 20 species of medicinal plants In this study, silica gelSephadex LH-20. and a thin layer of chromatography were used to screen and isolate active anti-hepatitis B virus compounds from Hypericum japonica that was extracted with 60% ethanol. Four compounds were separated from the ethyl acetate extract of II center dot japonica and their structures were identified by spectral chemical and structural analyses. In addition, using HepG2 2.2.15 cell line with the cytotoxicity and inhibitory effecting on the secretion of HBeAg and HBsAg of the 4 isolated compounds were examined by MTT and enzyme-linked immunosorbent assays. The four isolated compounds were determined and 1,3,6,7-tetrahydroxy-9H-xanthen-9-one (Compound 4) exhibited the highest activity in inhibiting secretion of HBeAg in HepG2 2.2.15cells. The results indicated a 67.66% of inhibition rate, 40.25 mu g /mL of IC50 value and TI > 2. We conducted a qualitatively evaluated research using duck hepatitis B virus model in vivo, the results indicated that ethanol extracts of H. japonica had anti-HBV effects and almost no sign of disease rebound after drug withdrawing. But the compound 4 has no direct inhibitory effect on HBV-DNA in duck experiment.
引用
收藏
页数:5
相关论文
共 13 条
  • [1] A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus
    Addison, WR
    Wong, WWS
    Fischer, KP
    Tyrrell, DLJ
    [J]. ANTIVIRAL RESEARCH, 2000, 48 (01) : 27 - 37
  • [2] [Anonymous], 2012, HEP B, V204
  • [3] Drug Delivery Systems and Liver Targeting for the Improved Pharmacotherapy of the Hepatitis B Virus (HBV) Infection
    Cuestas, Maria L.
    Mathet, Veronica L.
    Oubina, Jose R.
    Sosnik, Alejandro
    [J]. PHARMACEUTICAL RESEARCH, 2010, 27 (07) : 1184 - 1202
  • [4] Antiviral therapeutic efficacy of foscarnet in hepatitis B virus infection
    Han, YX
    Xue, R
    Zhao, W
    Zhou, ZX
    Li, JN
    Chen, HS
    Chen, XH
    Wang, YL
    Li, YH
    Wu, YW
    You, XF
    Zhao, LX
    Jiang, JD
    [J]. ANTIVIRAL RESEARCH, 2005, 68 (03) : 147 - 153
  • [5] Jiang Su-zhen, 2012, INFECT INT NATL, V1, P14
  • [6] Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model
    Le Guerhier, F
    Thermet, A
    Guerret, S
    Chevallier, M
    Jamard, C
    Gibbs, CS
    Trépo, C
    Cova, L
    Zoulim, F
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 (03) : 328 - 334
  • [7] Chronic hepatitis B in hepatocarcinogenesis
    Park, N. H.
    Song, I. H.
    Chung, Y-H
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2006, 82 (970) : 507 - 515
  • [8] A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes
    Shin, MS
    Kang, EH
    Lee, YI
    [J]. ANTIVIRAL RESEARCH, 2005, 67 (03) : 163 - 168
  • [9] Management of chronic hepatitis B infection: Current treatment guidelines, challenges, and new developments
    Tang, Ceen-Ming
    Yau, Tung On
    Yu, Jun
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (20) : 6262 - 6278
  • [10] Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil
    Westland, C
    Delaney, W
    Yang, HL
    Chen, SS
    Marcellin, P
    Hadziyannis, S
    Gish, R
    Fry, J
    [J]. GASTROENTEROLOGY, 2003, 125 (01) : 107 - 116